|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Dez―20 |
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults |
Maura C. Dodge, Christina Ellervik, Yachana Kataria |
2 |
[GO] |
2022―Nov―08 |
Review of SARS-CoV-2 Antigen and Antibody Testing in Diagnosis and Community Surveillance |
Robert D. Nerenz, Jacqueline A. Hubbard, Mark A. Cervinski |
3 |
[GO] |
2022―Mai―27 |
Covid-19 Molecular Testing and Clinical Correlates |
Sanjat Kanjilal, Yi-Wei Tang |
4 |
[GO] |
2022―Apr―06 |
A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic |
Sanjat Kanjilal, Yi-Wei Tang |
5 |
[GO] |
2022―Mrz―09 |
Novel assays for molecular detection of SARS-CoV-2 |
Kyle G. Rodino, Kenneth P. Smith, Matthew A. Pettengill |
6 |
[GO] |
2022―Mrz―08 |
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe |
Emma Davies, Hamzah Z. Farooq, Benjamin Brown, Peter Tilston, Ashley McEwan, Andrew Birtles, et al. (+5) Robert O’Hara, Shazaad Ahmad, Nicholas Machin, Louise Hesketh, Malcolm Guiver |
7 |
[GO] |
2022―Mrz―08 |
Strategies for Scaling Up SARS-CoV-2 Molecular Testing Capacity |
Sanchita Das, Karen M. Frank |
8 |
[GO] |
2022―Mrz―08 |
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States |
Jennifer Dien Bard, N Esther Babady |
9 |
[GO] |
2022―Mrz―04 |
Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2 |
Nicole V. Tolan, Gary L. Horowitz |
10 |
[GO] |
2022―Mrz―04 |
SARS-CoV-2 molecular diagnostics in China |
Yanjun Lu, Ziyong Sun |
11 |
[GO] |
2022―Mrz―04 |
Rapid antigen assays for SARS-CoV-2: Promise and peril |
Thao T. Truong, Jennifer Dien Bard, Susan M. Butler-Wu |
12 |
[GO] |
2022―Mrz―01 |
Approaches to deployment of molecular testing for SARS-CoV-2 in resource-limited settings |
Gama Bandawe, Moses Chitenje, Joseph Bitiliyu Bangoh, Elizabeth Kampira |
13 |
[GO] |
2022―Feb―22 |
Performance of Non-Nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2 |
Benjamin Kukull, Salika M. Shakir, Kimberly E. Hanson |
14 |
[GO] |
2022―Feb―21 |
Cycle threshold values from SARS-CoV-2 PCR assays: Interpretation and potential use cases |
Alexander J. McAdam |
15 |
[GO] |
2022―Feb―21 |
Analytic and clinical performance of major commercial SARS-CoV-2 molecular assays in the United States |
Michelle R. Campbell, Matthew J. Binnicker |
16 |
[GO] |
2022―Feb―10 |
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19 |
Daimon P. Simmons, Peter H. Schur |
17 |
[GO] |
2021―Dez―21 |
Preface: Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management |
Daimon P. Simmons, Peter H. Schur |
18 |
[GO] |
2021―Nov―03 |
Antibody dynamics and durability in COVID-19 |
Adam Zuiani, Duane R. Wesemann |
19 |
[GO] |
2021―Nov―03 |
Performance evaluation of lateral flow assays for COVID-19 serology |
Lucy Ochola, Paul Ogongo, Samuel Mungai, Jesse Gitaka, Sara Suliman |
20 |
[GO] |
2021―Nov―03 |
Coronavirus antigens as targets of antibody responses |
Alana F. Ogata, Roey Lazarovits, Augusta Uwamanzu-Nna, Tal Gilboa, Chi-An Cheng, David R. Walt |
21 |
[GO] |
2021―Nov―03 |
Alternative methods to detect SARS-CoV-2 antibodies |
Rashmi Patel, Siddharth Khare, Vinay S. Mahajan |
22 |
[GO] |
2021―Nov―03 |
Vaccine-induced SARS-CoV-2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection) |
Amy C. Sherman, Michael Desjardins, Lindsey R. Baden |
23 |
[GO] |
2021―Nov―03 |
SARS-CoV-2 Serology Testing - A Laboratory Primer |
Patricia R. Slev |
24 |
[GO] |
2021―Nov―03 |
Performance Characteristics of High-Throughput Serologic Assays for SARS-CoV-2 with FDA Emergency Use Authorization: A Review |
Elitza S. Theel |
25 |
[GO] |
2020―Aug―08 |
Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic |
Andy Ngo, Debra Masel, Christine Cahill, Neil Blumberg, Majed Refaai |
26 |
[GO] |
2020―Aug―08 |
Coronavirus Detection in the Clinical Microbiology Laboratory: Are We Ready for Identifying and Diagnosing a Novel Virus? |
Katharine Uhteg, Karen C. Carroll, Heba H. Mostafa |
27 |
[GO] |
2020―Aug―08 |
Measuring the Serological Response to SARS-CoV-2: Methods and Meaning |
Nicole D. Pecora, Martin S. Zand |